Core operating profit (half year)
Operating profit adjusted for significant non-core items to reflect underlying business performance.
Unit million CHF Industry Pharmaceuticals
The chart
The figure
One published observation so far. A chart follows as soon as a second period is published.
Core operating profit (half year)
Global, as of 30 Jun 2026
Every record
All records
1 record · 1 region · 2026
| Period | Value | Source | Type |
|---|---|---|---|
| Global 1 record | |||
| as of 30 Jun 2026 | 11,856 million CHF | Roche · 23 Jul 2026 | actual |
Primary documents
Sources
1 document. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| [Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong momentum continues in the first half of 2026, delivering +6% sales growth at constant exchange rates; -2% in CHF due to the significant a... | Roche | 23 Jul 2026 | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Core operating profit (half year). Retrieved from https://statorigin.org/indicators/core-operating-profit-half-year